This site needs JavaScript to work properly. Please enable it to take advantage of the complete set of features!

Skip to main page content

Add to Collections

Your saved search

Name of saved search:

Search terms:

Test search terms

Would you like email updates of new search results?

Yes
No

Email: (change)

Frequency:

Which day?

Which day?

Report format:

Send at most:

Send even when there aren't any new results

Optional text in email:

Your RSS Feed

Comment

. 2010 Mar;122(2):169-71.

doi: 10.3810/pgm.2010.03.2136.

Use of rosuvastatin in preventing vascular events in patients with elevated C-reactive protein. Commentary

Robert M Guthrie¹

Affiliations

PMID: 20203470
DOI: 10.3810/pgm.2010.03.2136

Comment

Use of rosuvastatin in preventing vascular events in patients with elevated C-reactive protein. Commentary

Robert M Guthrie. Postgrad Med. 2010 Mar.

. 2010 Mar;122(2):169-71.

doi: 10.3810/pgm.2010.03.2136.

Author

Robert M Guthrie¹

Affiliation

¹ Department of Emergency Medicine, Ohio State University, Columbus, OH 42312, USA. guthrie.1@osu.edu

PMID: 20203470
DOI: 10.3810/pgm.2010.03.2136

No abstract available

PubMed Disclaimer

Comment on

Rosuvastatin to prevent vascular events in men and women with elevated C-reactive protein.
Ridker PM, Danielson E, Fonseca FA, Genest J, Gotto AM Jr, Kastelein JJ, Koenig W, Libby P, Lorenzatti AJ, MacFadyen JG, Nordestgaard BG, Shepherd J, Willerson JT, Glynn RJ; JUPITER Study Group. Ridker PM, et al. N Engl J Med. 2008 Nov 20;359(21):2195-207. doi: 10.1056/NEJMoa0807646. Epub 2008 Nov 9. N Engl J Med. 2008. PMID: 18997196 Clinical Trial.

Publication types

Actions

LinkOut - more resources

Full Text Sources
- Atypon
Research Materials
- NCI CPTC Antibody Characterization Program